1h-indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2- (carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1s,2r,3s)- has been researched along with cardiovascular agents in 2 studies
Studies (1h-indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2- (carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1s,2r,3s)-) | Trials (1h-indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2- (carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1s,2r,3s)-) | Recent Studies (post-2010) (1h-indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2- (carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1s,2r,3s)-) | Studies (cardiovascular agents) | Trials (cardiovascular agents) | Recent Studies (post-2010) (cardiovascular agents) |
---|---|---|---|---|---|
123 | 3 | 1 | 17,645 | 1,480 | 6,891 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bennett, T; Gardiner, SM; Kemp, PA; March, JE | 1 |
Brennan, P; Fouyas, IP; Kelly, PA; Whittle, IR | 1 |
2 other study(ies) available for 1h-indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2- (carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1s,2r,3s)- and cardiovascular agents
Article | Year |
---|---|
Cardiovascular effects of endothelin-1 and endothelin antagonists in conscious, hypertensive ((mRen-2)27) rats.
Topics: Anesthetics; Animals; Animals, Genetically Modified; Baroreflex; Blood Pressure; Butyrophenones; Cardiovascular Agents; Consciousness; Dioxoles; Dose-Response Relationship, Drug; Drug Combinations; Endothelin Receptor Antagonists; Endothelin-1; Female; Fentanyl; Heart; Heart Rate; Humans; Hypertension; Indans; Male; Medetomidine; Methohexital; Mice; Midazolam; Pyrazoles; Rats; Rats, Sprague-Dawley; Renin; Time Factors | 2000 |
The role of endothelin in the cerebrovascular response following intracerebral haemorrhage: experimental studies using the endothelin antagonist SB209670.
Topics: Animals; Cardiovascular Agents; Cerebral Hemorrhage; Cerebrovascular Circulation; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Hematoma; Indans; Rats; Rats, Inbred BB | 2008 |